Innovative Approach to Reduce Lung Cancer Stigma
- Conditions
- Stigma, SocialStigmatizationAcceptance ProcessesLung Cancer StigmaLung Cancer
- Interventions
- Behavioral: ACT-LCS Therapy
- Registration Number
- NCT03750864
- Lead Sponsor
- University of Arizona
- Brief Summary
This is a feasibility study examining the feasibility and acceptability of a novel psychotherapy intervention on lung cancer patients who are experiencing stigma.
- Detailed Description
Experiences of stigma (perception and internalization of negative appraisal and devaluation from others) are pervasive for lung cancer patients. Previous work has shown associations between lung cancer stigma and detriments in clinically relevant outcomes such as depression, lower quality of life, and reduced engagement in cancer care.
The investigators previously developed Acceptance and Commitment Therapy for Lung Cancer Stigma (ACT-LCS) as a patient-focused intervention to reduce the self-blame, guilt and inhibited disclosure associated with lung cancer stigma. ACT-LCS is based in Acceptance and Commitment Therapy (ACT), a cognitive-behavioral treatment that promotes psychological flexibility through acceptance and valued direction.
This is a feasibility study examining the feasibility and acceptability of ACT-LCS.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 24
- Proficiency in English
- Diagnosed with or treated for Non-Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC) within the prior 12 months.
- Scores of 37.5 on the Lung Cancer Stigma Inventory (LCSI) screening measure
- Not proficient in English
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description ACT-LCS Therapy ACT-LCS Therapy Intervention is psychosocial counseling utilizing Acceptance and Commitment Therapy for Lung Cancer Stigma (ACT-LCS) as a patient-focused intervention to reduce the self-blame, guilt and inhibited disclosure associated with lung cancer stigma.
- Primary Outcome Measures
Name Time Method Number of individuals who consent to the intervention 10 months This measure will be calculated as a function of those eligible and approached who consented to the intervention. It will be utilized as a metric of feasibility and acceptability.
Number of sessions that each consented patient attended 10 months This measure will be calculated as a count of sessions that each consented participant attended. It will be utilized as a metric of acceptability of the intervention among consented participants.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (2)
Memorial Sloan Kettering Cancer Center
🇺🇸New York, New York, United States
University of Arizona Cancer Center
🇺🇸Tucson, Arizona, United States